Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
When the 100% isodose value is edited on the isodose control rhe dose normalization is automatically updated. if the user does not notice this update and then rescales to the relative isoline and does not read the dose normalization value displayed on the rescale bar the rescale could be other than intended. when the user optimizes then changes the bolus assigment of the beams and then selects "calculate" (not "optimize" again) the bolus assignment to beams can get scrambled.